Answers from the Lab
Trailer
Bonus
Episode 160
Season 1
FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.
(00:32)
Can you please tell our listeners a little about yourself and your background?
(01:00)
Mayo Clinic Laboratories already offers one test for Alzheimer's disease, right?
(01:32)
Could you tell our listeners about the new FDA-approved test that Mayo Clinic Laboratories will launch soon?
(02:43)
The test results will report the ratio of the amyloid isoforms, not the individual test components, right?
(03:26)
Does the new test require a certain tube?
(04:15)
Can you provide a little more detail on the commercially available tube that will be required?
(04:36)
Which patient population would benefit most from this test?
(05:30)
Can you compare and contrast the existing Alzheimer's disease test and the new amyloid ratio evaluation?
(08:58)
Is Mayo Clinic's ADEVL the only test that measures the tau component?
(09:51)
When would one of these tests be more appropriate than the other?
(10:52)
Can you help our listeners understand what a "laboratory developed" test means?
(11:43)
From a physician's standpoint, how might this new test improve patient care?